Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eduardo E. Romero
Observed names:
Eduardo E Romero,
Eduardo Romero,
Eduardo E Romero
Institution:
University of Nebraska–Lincoln
Observed institutions:
Dartmouth College,
University of Nebraska–Lincoln,
National Laboratory of the Rockies,
SLAC National Accelerator Laboratory,
University of Colorado Anschutz
ORCID:
0000-0002-0793-9948
Observed ORCID:
0000-0002-0793-9948
OpenAlex ID:
A5118676964
Structural characterization and dynamics of AdhE ultrastructures from Clostridium thermocellum show a containment strategy for toxic intermediates
2024
·
Samantha J. Ziegler
, Brandon C. Knott
, et al.
·
eLife
·
5
The human primosome requires replication protein A when copying DNA with inverted repeats
2025
·
Andrey G Baranovskiy
, Lucia M Morstadt
, et al.
·
Nucleic Acids Research
·
4
PDF
Structural characterization and dynamics of AdhE ultrastructures from Clostridium thermocellum: A containment strategy for toxic intermediates
2024
·
Samantha J Ziegler
, Brandon C Knott
, et al.
·
eLife
·
2
Structural characterization and dynamics of AdhE ultrastructures from Clostridium thermocellum: A containment strategy for toxic intermediates?
2024
·
Samantha J. Ziegler
, Brandon C. Knott
, et al.
·
eLife
·
1
Structural insights into HSV-1 origin unwinding by the viral proteins UL9 and ICP8
2026
·
Andrey G Baranovskiy
, Lucia M Morstadt
, et al.
·
Nucleic Acids Research
Author response: Structural characterization and dynamics of AdhE ultrastructures from Clostridium thermocellum show a containment strategy for toxic intermediates
2025
·
Samantha J Ziegler
, Brandon Knott
, et al.
·
eLife
Author response: Structural characterization and dynamics of AdhE ultrastructures from Clostridium thermocellum: A containment strategy for toxic intermediates
2024
·
Samantha J Ziegler
, Brandon C Knott
, et al.
·
eLife
Supplementary Methods from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S8 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S13 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S7 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Table S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S11 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S3 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S3 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Show more works
View as search
Works count:
28
Citation count:
12
H-index:
2
I10-index:
Year
Topic
Type